Investigators examined the benefits of the elemental diet in supporting the healing of the gut microbiome. A recent study ...

eosinophilic esophagitis and other gut ailments. The diet likely works by reducing inflammation, balancing the gut microbiome, healing the gut lining, and providing complete nutrition without ...

eosinophilic esophagitis and other gut ailments. The diet likely works by reducing inflammation, balancing the gut microbiome, healing the gut lining, and providing complete nutrition without ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

Eosinophilic esophagitis (EoE) is a long-term immune ... The main ways to do that are with diet changes and medication. Treatments include: An elimination diet. This involves removing certain ...

The first prospective trial of a palatable elemental diet shows symptom improvement, microbiome changes, and full adherence ...

Eosinophilic esophagitis (EoE) is a rare inflammatory disease of the esophagus, the tube that connects your mouth to your stomach. If you have EoE, a type of white blood cell known as an ...

including the first FDA-approved treatment for eosinophilic esophagitis in 2022." "We are the leading group of experts that studies these diseases, publishes articles, educates the public ...

A new study from Cedars-Sinai has examined whether a specialized diet could improve symptoms of ... Rezaie and his team of investigators plan to conduct larger studies to better understand the ...

A special diet could ease symptoms of gut disorders caused ... Rezaie and his team of investigators plan to conduct larger studies to better understand the long-term effects of elemental diets ...

in San Diego.The study aims to investigate markers in the blood of patients with Eosinophilic esophagitis (EoE) in order to find new methods to diagnose and follow up treatment in the future. The aim ...

NS-229 is currently being evaluated in a phase 2 trial in patients with eosinophilic granulomatosis with polyangiitis. The Food and Drug Administration (FDA) has granted Orphan Drug designation to ...